FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Pfizer Touts Favorable Covid Jab Data in Children

[ Price : $8.95]

Pfizer and BioNTech announce results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody re...

FDA Complete Response on Verrica NDA

[ Price : $8.95]

FDA sends Verrica Pharmaceuticals a complete response letter on its NDA for VP-102 for treating the skin disease molluscum contagi...

Latest Federal Register Notices

[ Price : $8.95]

FDA Review posts the Federal Register notices for the week ending 9/17/2021.

FDA OKs Neovasc IDE for Reducer Device Trial

[ Price : $8.95]

FDA approves a Neovasc IDE for its COSIRA-II IDE clinical trial that will evaluate the Reducer device and its use in treating cert...

Panel Backs Limited Covid Booster Shots

[ Price : $8.95]

An FDA advisory committee unanimously votes to recommend Pfizer-BioNTechs Comirnaty Covid-19 booster vaccine in individuals 65 yea...

Q & A Guide on Biosimilar Development

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Questions and Answers on Biosimilar Development and the BPC...

Pfizer Expands Chantix Recall to Include All Lots

[ Price : $8.95]

Pfizer expands its Chantix (varenicline) recall to include all lots of 0.5 mg and 1 mg tablets because of the potential presence o...

FDA Safety Alert on Greenpark Compounded Drugs

[ Price : $8.95]

An FDA safety alert warns healthcare professionals and patients not to use compounded products from Prescription Labs, doing busin...

Consent Decree Against Florida Drug Outsourcer

[ Price : $8.95]

A Florida federal court enters a consent decree against Premier Pharmacy Labs that prohibits it from producing or distributing any...

FDA Clinical Hold on Protagonist Rusfertide Studies

[ Price : $8.95]

FDA places a clinical hold against three Protagonist Therapeutics clinical studies for rusfertide due to concerning mouse study fi...